Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D005680 |
gamma-Aminobutyric Acid |
Etomidate promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRE]] | affects binding|increases activity|increases reaction | 10049148
|
D005680 |
gamma-Aminobutyric Acid |
Pentobarbital promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRE]] | affects binding|increases activity|increases reaction | 10049148
|
D005680 |
gamma-Aminobutyric Acid |
Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRE]] | affects binding|increases activity|increases reaction | 10049148
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GABRE mRNA | affects expression | 16483693
|
D001569 |
Benzodiazepines |
GABRE protein results in decreased susceptibility to Benzodiazepines | decreases response to substance | 11691872
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of GABRE mRNA | increases expression | 20106945
|
D002707 |
Chlordiazepoxide |
GABRE protein results in decreased susceptibility to Chlordiazepoxide | decreases response to substance | 11691872
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of GABRE mRNA | decreases expression | 20106945
|
D004958 |
Estradiol |
Estradiol results in increased expression of GABRE mRNA | increases expression | 16000229
|
D005045 |
Etomidate |
Etomidate promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRE]] | affects binding|increases activity|increases reaction | 10049148
|
C034818 |
methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate |
GABRE protein results in decreased susceptibility to methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate | decreases response to substance | 11691872
|
D008874 |
Midazolam |
GABRE protein results in decreased susceptibility to Midazolam | decreases response to substance | 11691872
|
D010424 |
Pentobarbital |
Pentobarbital promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRE]] | affects binding|increases activity|increases reaction | 10049148
|
D010424 |
Pentobarbital |
Pentobarbital results in increased activity of [GABRA1 binds to GABRB1 binds to GABRE] | affects binding|increases activity | 10049148
|
D010424 |
Pentobarbital |
GABRE protein results in decreased susceptibility to Pentobarbital | decreases response to substance | 9039914
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GABRE mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of GABRE mRNA | decreases expression | 17950772
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of GABRE mRNA] | decreases expression|increases reaction | 17950772
|
C025299 |
polyphenols |
polyphenols results in decreased expression of GABRE mRNA | decreases expression | 16293270
|
D011280 |
Pregnanolone |
GABRE protein results in decreased susceptibility to Pregnanolone | decreases response to substance | 9039914
|
D015742 |
Propofol |
Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRE]] | affects binding|increases activity|increases reaction | 10049148
|
D015742 |
Propofol |
GABRE protein results in decreased susceptibility to Propofol | decreases response to substance | 9039914
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of GABRE mRNA | increases expression | 12377990
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.87 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.58 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.12 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.28 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.28 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.65 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.97 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.97 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.95 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Pentobarbital |
4.73 | 18313124 11141031 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.09 | 19183758 |
MESH:D001321 |
Autistic Disorder |
|
Benzodiazepines |
4.68 | 17630868 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.78 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.78 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.82 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.76 | 15746008 |
MESH:D001930 |
Brain Injuries |
|
Pregnanolone |
6.22 | 15665606 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.79 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.79 | 16675129 12948864 18497071 17289903 19861407 17261762 17018787 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.79 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.48 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.80 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
1.76 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.05 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.37 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.58 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.58 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.76 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.76 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.10 | 16354765 15340226 15668235 8697196 12621046 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.67 | 16293270 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.06 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 15322242 10048152 20055451 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.43 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.41 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Pregnanolone |
6.46 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
3.98 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.98 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.76 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.55 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.55 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.93 | 18230668 15322242 16714409 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.98 | 18566989 19148513 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.02 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.01 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.01 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.58 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.58 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.47 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.53 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.53 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.24 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.62 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.45 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.45 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.54 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.44 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.34 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.31 | 16221962 18467677 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.31 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.06 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.78 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.08 | 8697196 18606429 15340226 16959395 16354765 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.19 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.95 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.95 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
polyphenols |
5.15 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.15 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.20 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.20 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.47 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.94 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.94 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.28 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.28 | 15610895 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.38 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.38 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.38 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
2.78 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.32 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.32 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.32 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.11 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.18 | 18520028 18816296 20064080 20464547 17053015 18569708 20869020 20135361 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.18 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.56 | 11807958 11408345 16891317 17203775 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.51 | 19453300 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.82 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.19 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.52 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.14 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.02 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.26 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.26 | 16411023 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.82 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.82 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.75 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.47 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.29 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.50 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.50 | 14600291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.81 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.22 | 19401270 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.28 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.57 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.22 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.21 | 11896295 11118676 11222880 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.89 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.11 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.11 | 16740699 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.23 | 16882103 |
MESH:D011595 |
Psychomotor Agitation |
|
Benzodiazepines |
6.91 | 20581379 |
MESH:D012021 |
Reflex, Abnormal |
|
Pentobarbital |
6.04 | 10930210 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.39 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 18990726 |
MESH:D012640 |
Seizures |
|
Midazolam |
7.16 | 10087439 |
MESH:D012640 |
Seizures |
|
Pentobarbital |
7.16 | 10087439 9754883 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.48 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.48 | 16192470 |
MESH:D012893 |
Sleep Disorders |
|
Midazolam |
6.03 | 6138072 |
MESH:D007319 |
Sleep Initiation and Maintenance Disorders |
|
Midazolam |
5.83 | 6138071 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Pentobarbital |
4.98 | 9754883 11529278 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.28 | 17997062 |
MESH:D013742 |
Tetanus |
|
Midazolam |
14.24 | 2903605 |
MESH:D013742 |
Tetanus |
|
Propofol |
14.24 | 2903605 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.93 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.72 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.18 | 17053015 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.01 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.62 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.28 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.47 | 17120751 |